Investigate Tolerability and PK of SAR164653 SAD/FE/MAD V1 22Jun11

• Research type

  Research Study

• Full title

  A randomized, double-blind, placebo-controlled study of the tolerability and pharmacokinetics of ascending single and 14-day repeated oral doses of SAR164653 with a pilot investigation of food effect in healthy subjects.

• IRAS ID

  84208

• Sponsor organisation

  Sanofi Aventis

• Eudract number

  2011-001980-30

• Clinicaltrials.gov Identifier

  NA

• Research summary

  Research Summary not published at request of researcher

• REC name

  East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

• REC reference

  11/IE/0113

• Date of REC Opinion

  2 Aug 2011

• REC opinion

  Further Information Favourable Opinion